ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 967

Haplotypes of GTP Cyclophydrolase Gene Polymorphisms Are Protective in the Susceptibility of Fibromyalgia Syndrome

Hwajeong Lee1, Shin-Seok Lee2, Seong-Kyu Kim3, Jung-Yoon Choe4, Seong-Ho Kim KIM5, Seong-Su Nah6, Ji Hyun Lee7, Seung-Jae Hong8, Hyun-Sook Kim9, Hye-Soon Lee10, Hyun Ah Kim11 and Chung-Il Joung12, 1Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, 2Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 3Catholic University of Daegu School of Medicine, Daegu, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, 5Department of Internal Medicine,, Inje University Haeundae Paik Hospital, Busan, South Korea, 6Department of Internal Medicine, Soonchunhyang University, College of Medicine, Cheonan, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 8Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 9Internal Medicine, Chosun University Hospital, Gwangju, South Korea, 10Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 11Division of Rheumatology, Department of Internal Medicine, Hallym university, Kyunggi, South Korea, 12Department of Internal Medicine, Konyang university hospital, Daejeon, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fibromyalgia, pain and polymorphism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Guanosine triphosphate cyclohydrolase 1 (GCH1) is the rate-limiting enzyme in the synthesis of tetrahydrobiopterin, which is an essential co-factor in nitric oxide (NO) production. Polymorphisms in the GCH1 gene have been implicated in protection against pain sensitivity. Our study was to determine whether single nucleotide polymorphisms (SNPs) in the GCH1 gene affect susceptibility and/or pain sensitivity in fibromyalgia syndrome (FMS).

Methods: A total of 409 FMS patients and 422 controls were enrolled. The alleles and genotypes at four positions, rs3783641(T>A), rs841(C>T), rs752688(C>T), and rs4411417(T>C), in the GCH1 gene were analyzed. The associations of the GCH1 SNPs with susceptibility and clinical parameters in FMS patients were assessed.

Results: The frequencies of alleles and genotypes of the four SNPs did not differ between FMS patients and healthy controls. Among 13 constructed haplotypes, we further examined four (CCTT, TTCT, TTCA, and CCTA) with >1% frequency in both FMS and controls. No associations of GCH1 polymorphisms with FMS-related activity or severity indexes were found, although the number and total score of tender points in FMS patients differed among the four haplotypes (p = 0.03 and p = 0.01, respectively). The CCTA haplotype of GCH1 was associated with significantly lower pain sensitivity and occurred less frequently than the CCTT haplotype in FMS patients (OR = 0.45; 95% CI, 0.21–0.96).

Conclusion: This study provides evidence that certain GCH1 haplotypes may be protective against susceptibility and pain sensitivity in FMS. Our data also suggest that NO is responsible for pain sensitivity in the pathogenesis of FMS.


Disclosure:

H. Lee,
None;

S. S. Lee,
None;

S. K. Kim,
None;

J. Y. Choe,
None;

S. H. K. KIM,
None;

S. S. Nah,
None;

J. H. Lee,
None;

S. J. Hong,
None;

H. S. Kim,
None;

H. S. Lee,
None;

H. A. Kim,
None;

C. I. Joung,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/haplotypes-of-gtp-cyclophydrolase-gene-polymorphisms-are-protective-in-the-susceptibility-of-fibromyalgia-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology